David Hagerty

Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition

Mark C. Genovese, Jean‐Claude Becker, Michael Schiff et al. · New England Journal of Medicine · 2005 · 1.2K citations · Full text

Treatment of Rheumatoid Arthritis by Selective Inhibition of T-Cell Activation with Fusion Protein CTLA4Ig

Joel M. Kremer, René Westhovens, Marc Léon et al. · New England Journal of Medicine · 2003 · 1.1K citations · Full text

Costimulation Blockade with Belatacept in Renal Transplantation

Flavio Vincenti, Christian P. Larsen, Antoine Dürrbach et al. · New England Journal of Medicine · 2005 · 851 citations · Full text

Rational Development of LEA29Y (belatacept), a High-Affinity Variant of CTLA4-Ig with Potent Immunosuppressive Properties

Christian P. Larsen, Thomas C. Pearson, Andrew Adams et al. · American Journal of Transplantation · 2005 · 707 citations · Full text

Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies

Edward Keystone, Paul Emery, Charles Peterfy et al. · Annals of the Rheumatic Diseases · 2008 · 240 citations · Full text